CRISPR/Cas9-mediated inactivation of miR-34a and miR-34b/c in

MicroRNA-202 safeguards meiotic progression by preventing

Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression. - Abstract - Europe PMC

miR-34a targets the IRE1α branch of the UPR. (A,B,C) Schematic

miR-34a exerts as a key regulator in the dedifferentiation of

Biomedicines, Free Full-Text

PDF] The Critical Role of Dysregulated FOXM1–PLAUR Signaling in Human Colon Cancer Progression and Metastasis

Diseases, Free Full-Text

Diseases, Free Full-Text

Activation of miR-34a impairs autophagic flux and promotes cochlear cell death via repressing ATG9A: implications for age-related hearing loss

Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges